Objectives: To determine the extent to which newborns with neonatal abstinence syndrome (NAS) are concentrated in some hospitals as compared with newborns without NAS and whether care quality and safety differed among these hospitals. We hypothesized that newborns with NAS would be cared for in poorer-quality hospitals.

Methods: Secondary analysis of 3 2016 data sets: (1) the panel study of effects of changes in nursing on patient outcomes-US survey of hospital registered nurses regarding work conditions and safety, (2) inpatient discharge abstracts, and (3) the American Hospital Association annual survey. Newborns in 266 hospitals from the 4 states where the panel study of effects of changes in nursing on patient outcomes was conducted were included. We used Lorenz curves to determine if newborns with NAS were concentrated in different hospitals than newborns without NAS and whether care quality and safety differed among those hospitals. Quality and safety were assessed by staff nurses by using standard survey questions.

Results: Of the 659 403 newborns in this study, 3130 were diagnosed with noniatrogenic NAS. We found that newborns with NAS were cared for in different hospitals compared with newborns without NAS (Gini coefficient 0.62, 95% confidence interval, 0.56-0.68) and that the hospitals in which they received care were rated as having poorer quality and safety (Gini coefficient 0.12, 95% confidence interval, 0.01-0.23).

Conclusions: Newborns with NAS are cared for in poorer-quality hospitals than other newborns. Our findings are of concern because poorer-quality care is linked to patient outcomes. As stakeholders seek to address the opioid epidemic and improve outcomes of newborns with NAS, our findings suggest the importance of examining hospital factors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120655PMC
http://dx.doi.org/10.1542/hpeds.2020-003145DOI Listing

Publication Analysis

Top Keywords

newborns nas
32
quality safety
16
newborns
13
nas cared
12
nas
10
hospitals
9
newborns neonatal
8
neonatal abstinence
8
abstinence syndrome
8
poorer-quality hospitals
8

Similar Publications

Hypothermia as a Presenting Sign of Venlafaxine-Induced Neonatal Abstinence Syndrome in 2 Neonates.

J Pediatr Pharmacol Ther

December 2024

Department of Pharmacy (MO, GE-C), NYU Langone - Long Island, Department of Pediatrics (MC), NYU Langone - Long Island, Mineola, NY.

Maternal antidepressant use has increased during the past 2 decades, with venlafaxine emerging as a common agent during pregnancy. Both venlafaxine and its active metabolite possess prolonged half-lives in adults; however, abrupt discontinuation may lead to withdrawal including irritability, jitteriness, lethargy, restlessness, and insomnia. The drug and its metabolite readily cross the placenta, posing additional considerations during pregnancy.

View Article and Find Full Text PDF
Article Synopsis
  • Neonatal abstinence syndrome (NAS) is a condition affecting infants due to in-utero exposure to substances, particularly opioids, and can cause long-term developmental issues; interdisciplinary teams can help mitigate these effects but often lack adequate training and support.* -
  • Project SCOPE aimed to enhance the capabilities of providers working with NAS-affected families by training 14 sites in the ECHO model and SCOPE curriculum, which they implemented over 2019-2022, reaching about 9,392 individuals in 33 states.* -
  • Analysis of participant surveys revealed high satisfaction (96.4%) with the sessions, significant gains in knowledge and skills related to NAS, and increased motivation to work with affected populations; nearly
View Article and Find Full Text PDF

Background: In 2020, the rate of newborns diagnosed with neonatal abstinence syndrome (NAS) in the United States was 6.3 for every 1000 newborn hospitalizations. Resources used to care for this population, particularly NICU beds, are being overwhelmed.

View Article and Find Full Text PDF

Antioxidant Therapy in Neonatal Hypoxic Ischemic Encephalopathy: Adjuvant or Future Alternative to Therapeutic Hypothermia?

Metabolites

November 2024

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.

Article Synopsis
  • Oxidative stress-related diseases in newborns are caused by an imbalance between pro-oxidants and antioxidants, affecting both term and preterm infants, and are associated with conditions like hypoxic ischemic encephalopathy (HIE) and retinopathy of prematurity (ROP).
  • A comprehensive review of literature from 2012-2024 highlighted various antioxidant therapies—including melatonin and N-acetylcisteine—that have been investigated for their effectiveness in treating these oxidative stress-related diseases in newborns.
  • Current findings suggest that therapies like melatonin, allopurinol, and stem cells could serve as potential alternatives to the standard treatment of therapeutic hypothermia for newborns suffering
View Article and Find Full Text PDF

Introduction: Prenatal opioid exposure (POE) is a major public health consequence of the opioid epidemic. Long-term health outcomes associated with POE remain unclear, especially for children with POE without a diagnosis of neonatal abstinence syndrome (NAS). Here, we aimed to describe the health outcomes of children with POE and with POE and NAS compared to unexposed children during the first 7 years of life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!